Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Robert H. Collins, John Nemunaitis, Ofer Shpilberg et al.|Journal of Clinical Oncology|1997Cited by 1.3k
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesBart L. Scott, Mitchell E. Horwitz, Hugo F. Fernández et al.|Journal of Clinical Oncology|2017Cited by 664
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual DiseaseChristopher S. Hourigan, Mitchell E. Horwitz, Laura W. Dillon et al.|Journal of Clinical Oncology|2019Cited by 441
Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★Ran Reshef, Daniel Tsai, Saran Vardhanabhuti et al.|American Journal of Transplantation|2011Cited by 218
Circulating Osteogenic Precursor Cells in Heterotopic Bone FormationRobin K. Suda, Robert J. Pignolo, Paul C. Billings et al.|Stem Cells|2009Cited by 127